Position in ALT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$254,864
-$134,414 QoQ
Shares Held
83,837
-33.7% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 210 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $101,442,658 across 6 Biotechnology names. ALT ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
74,200 | $46,266,668 | |
| 2 | INCY |
Incyte Corp
|
318,584 | $36,114,682 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
137,395 | $18,236,438 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
10,891 | $396,541 | |
| 5 | ALT |
Altimmune, Inc.
This page
|
83,837 | $254,864 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
28,344 | $173,465 |
All Filings in ALT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,864 | 83,837 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $389,278 | 126,389 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $622,937 | 172,559 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||